Global Health, a company in the Hospital industry, reported revenue of ₹1,469 crore and net profit of ₹219 crore for the September 2026 quarter.
Global Health (NSE: MEDANTA) closed at ₹1,480.20 on 20 Nov 2026, up 22.0% over the past year. Its market capitalisation is ₹39,799 crore and it trades at 61.5 times earnings.
Global Health Limited operates a network of multi-specialty tertiary and quaternary care hospitals under the Medanta brand, primarily across North and East India. The company specialises in cardiac sciences, oncology, neurosciences, digestive and hepatobiliary sciences, orthopaedics, organ transplantation, kidney and urology, and other complex medical procedures. As of June 2026, Medanta operated six hospitals across Gurugram, Lucknow, Patna, Ranchi, Indore and Noida, supported by an expanding diagnostics, pharmacy and outpatient network.
Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.